Approvals/TGA/COSENTYX secukinumab (rch) 300 mg/2 mL solution for injection pre-filled pen

Approved

STANDARD

COSENTYX secukinumab (rch) 300 mg/2 mL solution for injection pre-filled pen

Approval Id: 9ad56f15956090ec
Product Name: COSENTYX secukinumab (rch) 300 mg/2 mL solution for injection pre-filled pen
Artg Id: 353266
Artg Name: COSENTYX secukinumab (rch) 300 mg/2 mL solution for injection pre-filled pen
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date: 2022-02-02
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/3280856f2231459f2f50f205bcb743d1.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/7a64729f9257789789292e8f7ecc6537.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

9ad56f15956090ec

Type

Standard